Loading the company…
Loading the company…
Families: Bone graft & orthobiologics, Lumbar fusion.
All companies · Product and company coverage
In the last ten years FDA made 1 decision for Biomendex Oy (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2026 (1). The latest was on 2026-02-17.
| Family | Decisions on record |
|---|---|
| Bone graft & orthobiologics | 1 |
| Lumbar fusion | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-02-17 | 510(k) | K253524 | Adaptos®Fuse Bone Graft |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Biomendex Oy.